Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 360.25
+5.35 (1.51%)
Aug 13, 2025, 3:29 PM IST
Biocon Employees
Biocon had 16,315 employees as of March 31, 2024. The number of employees decreased by 230 or -1.39% compared to the previous year.
Employees
16,315
Change (1Y)
-230
Growth (1Y)
-1.39%
Revenue / Employee
$9,666,381
Profits / Employee
$235,979
Market Cap
473.59B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 16,315 | -230 | -1.39% |
| Mar 31, 2023 | 16,545 | 1,545 | 10.30% |
| Mar 31, 2022 | 15,000 | 1,500 | 11.11% |
| Mar 31, 2021 | 13,500 | 891 | 7.07% |
| Mar 31, 2020 | 12,609 | 1,266 | 11.16% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 42,497 |
| Mankind Pharma | 26,978 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Aurobindo Pharma | 26,015 |
Biocon News
- 4 days ago - Profit margins, US medicine supplies may get hit: Biocon - The Times of India
- 5 days ago - Biocon Q1 net profit falls 95% to Rs 31 crore - The Times of India
- 21 days ago - Biocon Biologics launches Nepexto, a biosimilar to Enbrel, in Australia - Business Upturn
- 4 weeks ago - Top stocks in focus on July 16: Biocon, Dixon Technologies, IndiGo, ICICI Lombard, HDFC Life and more - Business Upturn
- 5 weeks ago - Biocon to announce Q1 FY26 results on August 7 - Business Upturn
- 5 weeks ago - It’s wrong to blame Covid jabs for cardiac arrests: Biocon chief Kiran Mazumdar-Shaw - The Times of India
- 5 weeks ago - 'Caution Not Anti-Science': Siddaramaiah On Covid Vaccine-Sudden Death Claim - NDTV
- 5 weeks ago - Biocon Chief Counters Siddaramaiah's Covid Vaccine-Heart Attack Link Claim - NDTV